Duloxetine Recall 2024

Duloxetine Recall 2024. Thu, october 24, 2024, 10:52 am edt · 3 min read. Fda issued a class ii recall for the antidepressant duloxetine, manufactured by towa pharmaceutical europe, after detecting nitrosamine impurities, which are known carcinogens.


Duloxetine Recall 2024

The recall involves 7,107 bottles of duloxetine, which is sold under the brand name cymbalta by max molski • published october 24, 2024 • updated on october 24, 2024 at 6:31. The recall was initiated earlier this month.

Duloxetine Recall 2024 Images References :